Page last updated: 2024-11-05

trifluoperazine and Head and Neck Neoplasms

trifluoperazine has been researched along with Head and Neck Neoplasms in 1 studies

Head and Neck Neoplasms: Soft tissue tumors or cancer arising from the mucosal surfaces of the LIP; oral cavity; PHARYNX; LARYNX; and cervical esophagus. Other sites included are the NOSE and PARANASAL SINUSES; SALIVARY GLANDS; THYROID GLAND and PARATHYROID GLANDS; and MELANOMA and non-melanoma skin cancers of the head and neck. (from Holland et al., Cancer Medicine, 4th ed, p1651)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Körbel, C1
Linxweiler, M1
Bochen, F1
Wemmert, S1
Schick, B1
Meyer, M1
Maurer, H1
Menger, MD1
Zimmermann, R1
Greiner, M1

Other Studies

1 other study available for trifluoperazine and Head and Neck Neoplasms

ArticleYear
Treatment of SEC62 over-expressing tumors by Thapsigargin and Trifluoperazine.
    Biomolecular concepts, 2018, May-19, Volume: 9, Issue:1

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Calmodulin; Carcinoma, Squamous Cell; Cell

2018